Citation Impact
Citing Papers
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Tenascin-C Stimulates Glioma Cell Invasion through Matrix Metalloproteinase-12
2006
Tumour-cell invasion and migration: diversity and escape mechanisms
2003 Standout
Oral diseases: a global public health challenge
2019 Standout
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors
2013
Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema
2011
Long COVID: major findings, mechanisms and recommendations
2023 Standout
The DNA-damage response in human biology and disease
2009 StandoutNature
EGFR Antagonists in Cancer Treatment
2008 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Pancreatic cancer
2004 Standout
Matrix metalloproteinases and the regulation of tissue remodelling
2007 Standout
Tumor detection using 18F-labeled matrix metalloproteinase-2 inhibitor
2003
Symptoms tell it all: A systematic review of the value of symptom assessment to predict survival in advanced cancer patients
2012
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Ovarian cancer
2014 Standout
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
2001
Impact of Smoking and Smoking Cessation on Lung Cancer Mortality in the Asia-Pacific Region
2007
I’m so tired: biological and genetic mechanisms of cancer-related fatigue
2010
CHESS improves cancer caregivers’ burden and mood: Results of an eHealth RCT.
2013
Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome
2013
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
A Multicenter Study Comparing Two Numerical Versions of the Edmonton Symptom Assessment System in Palliative Care Patients
2010
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11
2002
Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis
2016 Standout
The molecular biology of head and neck cancer
2010 Standout
Putting tumours in context
2001 Standout
Molecular mechanisms of glioma invasiveness: the role of proteases
2003
Design, Synthesis, and Characterization of Potent, Slow-binding Inhibitors That Are Selective for Gelatinases
2002
Extracellular matrix structure
2015 Standout
Symptom Burden and Quality of Life in Survivorship
2014
Radiation, Inflammation, and Immune Responses in Cancer
2012
Multimodal biomedical AI
2022 Standout
The “All of Us” Research Program
2019 Standout
Educational interventions for cancer pain. A systematic review of systematic reviews with nested narrative review of randomized controlled trials
2014
Drug repurposing: progress, challenges and recommendations
2018 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy
2012
A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting
2013
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
2006
Molecular regulation of angiogenesis and lymphangiogenesis
2007 Standout
China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up
2011
A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment
2013
Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents
2002
Optical Imaging of Matrix Metalloproteinase–2 Activity in Tumors: Feasibility Study in a Mouse Model
2001
Socioeconomic inequalities and oral cancer risk: A systematic review and meta‐analysis of case‐control studies
2008
A phase 3 randomized, placebo‐controlled, double‐blind, clinical trial of the effect of modafinil on cancer‐related fatigue among 631 patients receiving chemotherapy
2010
Transcription — guarding the genome by sensing DNA damage
2004
Symptoms and Quality of Life in Diverse Patients Undergoing Hematopoietic Stem Cell Transplantation
2012
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
Proton Therapy for Head and Neck Cancers
2017
Identification of human brain tumour initiating cells
2004 StandoutNature
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Asymmetric Multicomponent Reactions (AMCRs): The New Frontier
2005 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: Preliminary findings
2012
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Tumor Angiogenesis
2008 Standout
Interleukin-8 and human cancer biology
2001
Prevalence, predictors, and prognostic impact of fatigue among Brazilian outpatients with advanced cancers
2012
Iron-Catalyzed Reactions in Organic Synthesis
2004 Standout
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
2000
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Head and Neck Cancer
2020 Standout
American Cancer Society prostate cancer survivorship care guidelines
2014
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2
2003
Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review
2008
Equitably improving outcomes for cancer survivors and supporting caregivers: A blueprint for care delivery, research, education, and policy
2018
Improvement of hepatic fibrosis and patient‐reported outcomes in non‐alcoholic steatohepatitis treated with selonsertib
2018
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Inflammation and Behavioral Symptoms After Breast Cancer Treatment: Do Fatigue, Depression, and Sleep Disturbance Share a Common Underlying Mechanism?
2011
Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy
2004 Standout
COVID-19 symptoms over time: comparing long-haulers to ME/CFS
2021
SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors
2012
What Is the Value of the Routine Use of Patient-Reported Outcome Measures Toward Improvement of Patient Outcomes, Processes of Care, and Health Service Outcomes in Cancer Care? A Systematic Review of Controlled Trials
2014
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Cancer treatment and survivorship statistics, 2016
2016 Standout
Matrix Metalloproteinase Inhibitors: Current Developments and Future Perspectives
2001
Cancer treatment and survivorship statistics, 2019
2019 Standout
Stromal Matrix Metalloproteinase-9 Regulates the Vascular Architecture in Neuroblastoma by Promoting Pericyte Recruitment
2004
Cancer Genome Landscapes
2013 StandoutScience
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Measuring the Symptom Burden of Lung Cancer: The Validity and Utility of the Lung Cancer Module of the M. D. Anderson Symptom Inventory
2011
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Feasibility of Long-Term Patient Self-Reporting of Toxicities From Home via the Internet During Routine Chemotherapy
2013
Do High Symptom Scores Trigger Clinical Actions? An Audit After Implementing Electronic Symptom Screening
2012
How Matrix Metalloproteinases Regulate Cell Behavior
2001 Standout
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
1999
Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening
2004 Standout
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
2015 Standout
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents
2003
Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion.
2000
Construction and Validation of Improved Triple Fusion Reporter Gene Vectors for Molecular Imaging of Living Subjects
2007 StandoutNobel
Recruitment of DNA Damage Checkpoint Proteins to Damage in Transcribed and Nontranscribed Sequences
2005 StandoutNobel
Works of Qiuling Shi being referenced
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes
2010
Does Recall Period Have an Effect on Cancer Patients' Ratings of the Severity of Multiple Symptoms?
2010
The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome
2016
Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update
2014
Assessing Persistent Cancer Pain: A Comparison of Current Pain Ratings and Pain Recalled from the Past Week
2008
Polymorphisms of cytosolic serine hydroxymethyltransferase and risk of lung cancer: A case–control analysis
2007
All-cause mortality and risk factors in a cohort of retired military male veterans, Xi'an, China: an 18-year follow up study
2007
Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy
2010
Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy
2012
Symptom burden in cancer survivors 1 year after diagnosis
2011
Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients
2004
Serum interleukin‐6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation
2008
Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes
2016
Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer
2009
Experimental animal models of pancreatic cancer (review).
2000
Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
1999
Symptom burden in cancer survivors 1 year after diagnosis: A report from the American Cancer Society's studies of cancer survivors.
2010
[A prospective study on smoking, quitting and mortality in a cohort of elderly in Xi'an, China].
2002
Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial
2011
No Association between hOGG1 Ser326Cys Polymorphism and Risk of Squamous Cell Carcinoma of the Head and Neck
2004
Reply to symptom burden in cancer survivors 1 year after diagnosis: A report from the American Cancer Society's Studies of Cancer Survivors
2011
Sex Differences in Risk of Lung Cancer Associated with Methylene-tetrahydrofolate Reductase Polymorphisms
2005